Company intelligence / Profile preview

D2V Clinical

Durham, North Carolina, United Stateslinkedin.com ↗

Ownership: Private
Development stage: Other

Overview

D2V Clinical is a full-service global CRO specializing in early-phase oncology, hematology, and rare disease drug development. The company leverages deep industry expertise to expedite program advancement for biopharmaceutical sponsors. Its leadership team includes former FDA reviewers and executives from major pharma companies. They have supported over 80 FDA reviews and more than 65 early-phase programs involving thousands of patients and sites worldwide

Therapeutic areas: OncologyRare DiseasesHematology
Modalities: small moleculesbiologics
Industry: Contract Research Organization

Partnerships

Partners broadly with biotech sponsors in the US and China

Beyond the preview

Go deeper on D2V Clinical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on D2V Clinical.

Explore the full profile